Infant Bacterial Therapeutics AB (publ) Interim report

Message from the CEO The speed of recruitment of preterm infants into our large phase 3 study significantly increased in the final three months of...

Related Keywords

Sweden ,Australia ,United Kingdom ,Stockholm ,Australian ,British ,Maria Ekdahl ,Staffan Stro ,Australian Patent Office ,Data Monitoring Committee ,Market Access ,British Journal ,Connection Study ,Nasdaq Stockholm ,Stockholm Stock Exchange Ibt B ,Infant Bacterial Therapeutics Ab ,Infant Bacterial Therapeutics ,Nbt ,Financial Report ,Premature Infants ,Preterm ,Orphan Drug ,